Spero Therapeutics, Inc. SPRO 36.13
Health Care · NASDAQ · Data as of 2026-10-28
Spero Therapeutics, Inc. (SPRO) has delivered +72.8% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1634 of 1968 stocks overall and #203 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
36.13
Overall Rank
#1634 / 1968
Sector Rank
#203 / 260
Revenue CAGR
+72.8%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio